Ryan Specialty Holdings, Inc.
51.97-1.56 (-2.91%)
Oct 28, 4:00:02 PM EDT · NYSE · RYAN · USD
Key Stats
Market Cap
13.72BP/E (TTM)
129.93Basic EPS (TTM)
0.40Dividend Yield
0.01%Recent Filings
8-K
Ryan appoints co-presidents
Ryan Specialty Holdings appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer, effective October 9, 2025, succeeding Jeremiah Bickham, who transitions to a strategic advisor role through January 1, 2026. Both executives bring over 30 years of insurance expertise, with Keogh joining in May 2025 from Aon and Mulshine advancing internally since 2012. This leadership shift bolsters operational and revenue strategies amid ongoing growth. Yet risks could alter expected benefits.
8-K
Bungert joins Ryan board
Ryan Specialty Holdings appointed Michael G. Bungert, a reinsurance veteran with over four decades of experience including as former Chairman of Aon Re Global, to its Board of Directors on September 3, 2025, assigning him to the Compensation and Governance Committee. This move brings strategic insurance insights to guide the firm's specialty operations. Bungert receives $120,000 annual cash pay and prorated $200,000 RSUs vesting immediately. His expertise bolsters governance amid industry innovation.
10-Q
Q2 FY2025 results
Ryan Specialty Holdings posted solid Q2 results, with total revenue climbing 23% year-over-year to $855.2 million, fueled by 7.1% organic growth (derived) and contributions from recent buys like Velocity and USQ. Net commissions and fees jumped 23.6% to $840.9 million, while operating income rose 16.2% to $191.1 million, though margins dipped slightly amid higher amortization from acquisitions. Acquisitions drove the momentum: Velocity closed February 2025 for $548.6 million cash plus $19.6 million contingent, adding $363.9 million goodwill and $216.4 million customer relationships (13-year life); USQ and 360 added niche underwriting muscle. Cash sat at $172.6 million with $1.2 billion revolver availability, but total debt hit $3.5 billion including a $1.7 billion term loan at SOFR + 2.25%. Free cash flow wasn't disclosed in the 10-Q. Yet competition in wholesale brokerage remains fierce.
8-K
Ryan Q2 revenue up 23%
Ryan Specialty Holdings reported Q2 2025 results with total revenue surging 23.0% to $855.2 million, fueled by 7.1% organic growth and acquisitions, yet property rates declined sharply. Adjusted EBITDAC climbed 24.5% to $308.4 million at a 36.1% margin, while adjusted diluted EPS rose 13.8% to $0.66. The board declared a $0.12 quarterly dividend, payable August 26. Full-year organic growth outlook dipped to 9.0%-11.0%. Acquisitions bolster capabilities, but market headwinds persist.
8-K
Ryan Specialty mourns director's passing
Ryan Specialty Holdings announced the unexpected passing of board member and Lead Director D. Cameron Findlay on July 16, 2025, who had served since 2012 and chaired the Compensation and Governance Committee. The board swiftly appointed John W. Rogers, Jr. as new Lead Director and Henry S. Bienen as committee chairperson. Findlay's decades of legal and executive expertise, from roles at Aon and Medtronic to government service, bolstered the firm's governance. This transition ensures continuity amid the loss of a key advisor.
IPO
Employees
Sector
Industry
AMBC
Ambac Financial Group, Inc.
8.46-0.07
BOW
Bowhead Specialty Holdings Inc.
24.01-0.99
CNA
CNA Financial Corporation
44.51-0.76
EIG
Employers Holdings Inc
40.70-0.57
HGTY
Hagerty, Inc.
11.06-0.12
IGIC
International General Insurance
21.98-0.03
JRVR
James River Group Holdings, Ltd
5.17-0.24
NMIH
NMI Holdings Inc
35.95+0.01
RNR
RenaissanceRe Holdings Ltd.
231.59-10.68
TIRX
TIAN RUIXIANG Holdings Ltd
0.99-0.01